This could be a key move for future growth.

That is a big risk investors take when trying to find the winners and losers within the biotech sector. While we made the ...

Biogen Inc. (NASDAQ:BIIB) is one of the 10 Most Undervalued NASDAQ Stocks to Buy Right Now. On June 29, it was reported that ...

Biogen stock has delivered a strong 57.5% return over the past year, and with the current valuation checks painting a mixed ...

Healthcare stocks are attractive in a choppy market. These funds, focusing on the broader sector, drugmakers, and biotechs, ...

Grey Matters Health (CSE:GREY, OTCQB:AGNPD, FRA:AGW0) announced that it has taken delivery of its first brain-dedicated ...

Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Amylyx ...

Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through clinical trials. While the Bay Area biotech has yet to set ...

When Scotland international rugby legend Doddy Weir bravely broke off a family holiday in New Zealand in 2017 to reveal he ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has completed enrollment in the pivotal cohort (Cohort 1) of the global Phase 3 REVEAL study evaluating obudanersen (ION582), an ...

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.